[PHARMA] YoY Annual (Unaudited) Result on 31-Dec-2013 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
YoY- -10.55%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 2,189,022 2,189,312 2,122,933 1,946,639 1,812,346 1,520,981 1,378,348 8.00%
PBT 72,017 112,722 125,580 92,997 103,313 73,186 45,462 7.96%
Tax -26,158 -28,138 -31,355 -36,236 -40,108 -20,401 -15,152 9.51%
NP 45,859 84,584 94,225 56,761 63,205 52,785 30,310 7.13%
-
NP to SH 45,599 84,044 93,844 55,200 61,710 52,157 30,384 6.99%
-
Tax Rate 36.32% 24.96% 24.97% 38.96% 38.82% 27.88% 33.33% -
Total Cost 2,143,163 2,104,728 2,028,708 1,889,878 1,749,141 1,468,196 1,348,038 8.02%
-
Net Worth 531,169 529,482 525,526 486,754 471,886 514,273 421,524 3.92%
Dividend
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div 41,457 77,674 72,486 41,477 41,187 35,304 10,698 25.30%
Div Payout % 90.92% 92.42% 77.24% 75.14% 66.74% 67.69% 35.21% -
Equity
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 531,169 529,482 525,526 486,754 471,886 514,273 421,524 3.92%
NOSH 259,377 258,915 258,880 258,911 117,677 117,682 106,985 15.88%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 2.09% 3.86% 4.44% 2.92% 3.49% 3.47% 2.20% -
ROE 8.58% 15.87% 17.86% 11.34% 13.08% 10.14% 7.21% -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 844.83 845.57 820.05 751.85 1,540.10 1,292.44 1,288.35 -6.78%
EPS 17.60 32.46 36.25 21.32 52.44 44.32 28.40 -7.65%
DPS 16.00 30.00 28.00 16.02 35.00 30.00 10.00 8.14%
NAPS 2.05 2.045 2.03 1.88 4.01 4.37 3.94 -10.30%
Adjusted Per Share Value based on latest NOSH - 258,868
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 151.89 151.91 147.30 135.07 125.75 105.53 95.64 8.00%
EPS 3.16 5.83 6.51 3.83 4.28 3.62 2.11 6.95%
DPS 2.88 5.39 5.03 2.88 2.86 2.45 0.74 25.39%
NAPS 0.3686 0.3674 0.3646 0.3377 0.3274 0.3568 0.2925 3.92%
Price Multiplier on Financial Quarter End Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 5.30 6.36 4.58 4.45 8.10 5.36 5.31 -
P/RPS 0.63 0.75 0.56 0.59 0.53 0.41 0.41 7.41%
P/EPS 30.12 19.59 12.63 20.87 15.45 12.09 18.70 8.26%
EY 3.32 5.10 7.91 4.79 6.47 8.27 5.35 -7.63%
DY 3.02 4.72 6.11 3.60 4.32 5.60 1.88 8.21%
P/NAPS 2.59 3.11 2.26 2.37 2.02 1.23 1.35 11.45%
Price Multiplier on Announcement Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 21/02/17 15/02/16 23/02/15 24/02/14 18/02/13 22/02/12 25/02/11 -
Price 5.12 6.19 5.28 4.29 7.80 5.90 5.35 -
P/RPS 0.61 0.73 0.64 0.57 0.51 0.46 0.42 6.41%
P/EPS 29.09 19.07 14.57 20.12 14.87 13.31 18.84 7.50%
EY 3.44 5.24 6.87 4.97 6.72 7.51 5.31 -6.97%
DY 3.13 4.85 5.30 3.73 4.49 5.08 1.87 8.95%
P/NAPS 2.50 3.03 2.60 2.28 1.95 1.35 1.36 10.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment